GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Global Cord Blood Corp (OTCPK:CORBF) » Definitions » Price-to-Owner-Earnings

Global Cord Blood (Global Cord Blood) Price-to-Owner-Earnings : (As of Apr. 26, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Global Cord Blood Price-to-Owner-Earnings?

As of today (2024-04-26), Global Cord Blood's share price is $1.25. Global Cord Blood does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Global Cord Blood's Price-to-Owner-Earnings or its related term are showing as below:


CORBF's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 25.325
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-04-26), Global Cord Blood's share price is $1.25. Global Cord Blood's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 was $0.64. Therefore, Global Cord Blood's PE Ratio for today is 1.94.

As of today (2024-04-26), Global Cord Blood's share price is $1.25. Global Cord Blood's EPS without NRI for the trailing twelve months (TTM) ended in was $0.66. Therefore, Global Cord Blood's PE Ratio without NRI for today is 1.88.

During the past 13 years, Global Cord Blood's highest PE Ratio without NRI was 2.03. The lowest was 0.00. And the median was 0.00.


Global Cord Blood Price-to-Owner-Earnings Historical Data

The historical data trend for Global Cord Blood's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Cord Blood Price-to-Owner-Earnings Chart

Global Cord Blood Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.83 8.72 5.00 6.21 5.72

Global Cord Blood Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.21 - - - 5.72

Competitive Comparison of Global Cord Blood's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Global Cord Blood's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Cord Blood's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Global Cord Blood's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Global Cord Blood's Price-to-Owner-Earnings falls into.



Global Cord Blood Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Global Cord Blood's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1.25/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Cord Blood  (OTCPK:CORBF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Global Cord Blood Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Global Cord Blood's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Cord Blood (Global Cord Blood) Business Description

Traded in Other Exchanges
N/A
Address
1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants.
Executives
Kent C Mccarthy 10 percent owner, other: Mbr 13(d) grp own 10% plus 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Fund Ii Lp 10 percent owner 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
7-2010 Grat 5 Under Kent C. Mccarthy Grat Tr Dtd 4-23-2010 other: 13 (d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
7-2010 Grat 6 Under Kent C Mccarthy Grat Tr Dtd 4-23-2010 10 percent owner, other: Member of 13(d) group owning m 7335 COTTONWOOD, SHAWNEE KS 66216
Mccarthy Family Sd, Llc 10 percent owner, other: 13 (d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Fund Ii, Llc other: 13(d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jhab Management Ii, Llc other: 13(d) group owning > 10% 7335 COTTONWOOD DRIVE, SHAWNEE KS 66216
Jcf Co Lf, L.p. other: 13(d) group owning > 10% 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Capital Management Llc other: Member of the group 13021 W 74TH ST, SHAWNEE KS 66216
Jayhawk China Fund Cayman Ltd other: Member of the group 930 TAHOE BLVD., 802-281, INCLINE VILLAGE NV 89451
Jayhawk Private Equity Gp Ii, L.p. 10 percent owner 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205
Jayhawk Private Equity, Llc 10 percent owner 5410 WEST 61ST PLACE, SUITE 100, MISSION KS 66205

Global Cord Blood (Global Cord Blood) Headlines

From GuruFocus